Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE-Reference-Cited by-同舟云学术

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE

Published:2020-07-09 Issue:12 Volume:22 Page:2241-2247
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Heller Simon¹^ORCID,Lingvay Ildiko²^ORCID,Marso Steven P.³,Philis‐Tsimikas Athena⁴,Pieber Thomas R.⁵^ORCID,Poulter Neil R.⁶,Pratley Richard E.⁷,Hachmann‐Nielsen Elise⁸,Kvist Kajsa⁸,Lange Martin⁸,Moses Alan C.⁸⁹,Andresen Marie Trock⁸,Buse John B.¹⁰,

Affiliation:

1. Department of Oncology and Metabolism University of Sheffield Sheffield UK

2. Department of Internal Medicine and Department of Population and Data Sciences University of Texas Southwestern Medical Center Dallas Texas USA

3. HCA Midwest Health Heart and Vascular Institute Overland Park Kansas USA

4. Scripps Whittier Diabetes Institute San Diego California USA

5. Department of Internal Medicine Medical University of Graz Graz Austria

6. Imperial Clinical Trials Unit, National Heart and Lung Institute Imperial College London London UK

7. AdventHealth Translational Research Institute Orlando Florida USA

8. Novo Nordisk A/S Søborg Denmark

9. Independent consultant, Novo Nordisk A/S Portsmouth New Hampshire USA

10. University of North Carolina School of Medicine Chapel Hill North Carolina USA

Funder